Skip to content

TIANYIN PHARMACEUTICAL CO., INC.

Delisted

CIK 1362718fmd_07GEBFKY9H4M5Q9QDZPTDQ60YXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2010 to Mar 31, 2015, 19 periods

Latest annual · FY2014

Millions
Total revenues
47
Gross profit
16
Operating income
3
Net income
(1)
Free cash flow
11

Latest quarter · Q3 FY2015

Millions
Total revenues
4
Gross profit
2
Operating income
(1)
Net income
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
-21.2%

TIANYIN PHARMACEUTICAL CO., INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$46.6 million$67.5 million-31%10-K 2014-12-09 · proof
Gross profit$15.9 million$26 million-38.9%10-K 2014-12-09 · proof
Operating income$2.7 million$9.3 million-71.2%10-K 2014-12-09 · proof
Net income-$644,952$6.7 million-109.7%10-K 2014-12-09 · proof
Cash from operating activities$2.5 million$12.9 million-81%10-K 2014-12-09 · proof
Total assets$107.1 million$110.1 million-2.8%10-Q 2015-03-13 · proof
Total liabilities$9.3 million$11.9 million-21.6%10-Q 2015-03-13 · proof
Cash and cash equivalents$16.1 million$26.8 million-39.9%10-K 2014-12-09 · proof
What was TIANYIN PHARMACEUTICAL CO., INC.'s revenue in fiscal 2014?
TIANYIN PHARMACEUTICAL CO., INC. reported revenue of $46.6 million for fiscal 2014 (the year ended Jun 30, 2014), against $67.5 million the year before (-31%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC
What was TIANYIN PHARMACEUTICAL CO., INC.'s gross profit in fiscal 2014?
TIANYIN PHARMACEUTICAL CO., INC. reported gross profit of $15.9 million for fiscal 2014 (the year ended Jun 30, 2014), against $26 million the year before (-38.9%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC
What was TIANYIN PHARMACEUTICAL CO., INC.'s operating income in fiscal 2014?
TIANYIN PHARMACEUTICAL CO., INC. reported operating income of $2.7 million for fiscal 2014 (the year ended Jun 30, 2014), against $9.3 million the year before (-71.2%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC
What was TIANYIN PHARMACEUTICAL CO., INC.'s net income in fiscal 2014?
TIANYIN PHARMACEUTICAL CO., INC. reported net income of -$644,952 for fiscal 2014 (the year ended Jun 30, 2014), against $6.7 million the year before (-109.7%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC
What was TIANYIN PHARMACEUTICAL CO., INC.'s cash from operating activities in fiscal 2014?
TIANYIN PHARMACEUTICAL CO., INC. reported cash from operating activities of $2.5 million for fiscal 2014 (the year ended Jun 30, 2014), against $12.9 million the year before (-81%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC
What are TIANYIN PHARMACEUTICAL CO., INC.'s total assets?
As of Jun 30, 2014, TIANYIN PHARMACEUTICAL CO., INC. reported total assets of $107.1 million, against $110.1 million a year earlier (-2.8%). Source: the 10-Q filed with the SEC on Mar 13, 2015 (restated). SEC
What are TIANYIN PHARMACEUTICAL CO., INC.'s total liabilities?
As of Jun 30, 2014, TIANYIN PHARMACEUTICAL CO., INC. reported total liabilities of $9.3 million, against $11.9 million a year earlier (-21.6%). Source: the 10-Q filed with the SEC on Mar 13, 2015 (restated). SEC
What are TIANYIN PHARMACEUTICAL CO., INC.'s cash and cash equivalents?
As of Jun 30, 2014, TIANYIN PHARMACEUTICAL CO., INC. reported cash and cash equivalents of $16.1 million, against $26.8 million a year earlier (-39.9%). Source: the 10-K filed with the SEC on Dec 9, 2014. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1362718&period_type=annual&limit=5"

Information only, not investment advice.